Australia markets closed

Kukje Pharma Co., Ltd. (002720.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
4,940.00-55.00 (-1.10%)
At close: 03:30PM KST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
135,372,691
135,372,691
126,583,403
119,745,569
130,394,721
Cost of revenue
68,148,048
68,148,048
63,329,270
65,275,254
65,590,075
Gross profit
67,224,642
67,224,642
63,254,133
54,470,315
64,804,646
Operating expenses
Research development
2,645,615
2,645,615
1,966,817
2,772,337
3,036,649
Selling general and administrative
43,136,212
43,136,212
27,576,354
26,327,588
21,161,986
Total operating expenses
69,213,785
69,213,785
57,981,605
56,146,218
58,763,272
Operating income or loss
-1,989,143
-1,989,143
5,272,528
-1,675,903
6,041,374
Interest expense
1,439,891
1,439,891
1,000,486
696,434
650,126
Income before tax
-6,680,611
-6,680,611
4,745,086
-1,110,257
5,593,579
Income tax expense
1,734,277
1,734,277
1,202,313
445,535
3,399,010
Income from continuing operations
-8,414,888
-8,414,888
3,542,774
-1,555,791
2,194,569
Net income
-8,415,187
-8,415,187
3,557,333
-1,559,131
2,203,001
Net income available to common shareholders
-8,415,187
-8,415,187
3,557,333
-1,559,131
2,203,001
Basic EPS
-445.52
-
167.62
-73.47
103.66
Diluted EPS
-445.52
-
167.62
-73.47
103.66
Basic average shares
19,464
-
21,223
21,222
21,252
Diluted average shares
19,464
-
21,223
21,222
21,252